Skip to main content

Find Clinical Trials

Home
Conditions
Inflammatory Breast Neoplasms

Clinical trial condition

Inflammatory Breast Neoplasms

Explore clinical trials studying Inflammatory Breast Neoplasms. Study availability and eligibility vary by location and protocol.

74 public trials 5 recruiting studies

Refine in advanced search Browse all conditions

Inflammatory Breast Neoplasms trial results

Completed

Interest of Maintenance Chemotherapy After Induction Treatment for Inflammatory Breast Cancer

NCT02324088

Conditions: Breast Diseases, Breast Neoplasms, Inflammatory Breast Cancer, +5 more
Locations: Not specified

View Trial Details

Completed

Denosumab as an add-on Neoadjuvant Treatment (GeparX)

NCT02682693

Conditions: Adenocarcinoma, Breast Cancer Female NOS, Breast Diseases, +18 more
Locations: Charité Campus Mitte Berlin, Germany

View Trial Details

Completed

Nanoparticle-based Paclitaxel vs Solvent-based Paclitaxel as Part of Neoadjuvant Chemotherapy for Early Breast Cancer (GeparSepto)

NCT01583426

Conditions: Adenocarcinoma, Breast Cancer Female NOS, Breast Diseases, +19 more
Locations: Helios-Klinikum Berlin-Buch Berlin, Germany

View Trial Details

Completed

Pilot Study of Zirconium-89 Bevacizumab Positron Emission Tomography for Imaging Angiogenesis in Patients With Inflammatory Breast Carcinoma Receiving Preoperative Chemotherapy

NCT01894451

Conditions: Breast Diseases, Breast Neoplasms, Inflammatory Breast Carcinoma, +5 more
Locations: Brigham and Womens Hospital Boston, Massachusetts, United States

Dana Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

Efficacy and Tolerance Study of Bevacizumab in Her2- Inflammatory Breast Cancer Patients

NCT00820547

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +6 more
Locations: Centre Paul Papin Angers, France

Institut Sainte Catherine Avignon, France

Centre Hospitalier Regional de Besancon - Hopital Jean Minjoz Besançon, France

Institut Bergonie Bordeaux, France

View all 28 locations

View Trial Details

Completed

Sunitinib Malate, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide Before Surgery in Treating Patients With Stage IIB-IIIC Breast Cancer

NCT00513695

Conditions: Breast Diseases, Breast Neoplasms, Breast Neoplasms, Male, +11 more
Locations: Anchorage Oncology Centre Anchorage, Alaska, United States

Katmai Oncology Group Anchorage, Alaska, United States

Arizona Cancer Center Tucson, Arizona, United States

Saint Luke's Mountain States Tumor Institute Boise, Idaho, United States

View Trial Details

Completed

TKI258 for Metastatic Inflammatory Breast Cancer Patients

NCT01262027

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +8 more
Locations: University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

MIRNA Profiling of Breast Cancer in Patients Undergoing Neoadjuvant or Adjuvant Treatment for Locally Advanced & Inflammatory Breast Cancer

NCT01231386

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +5 more
Locations: City of Hope Duarte, California, United States

View Trial Details

Completed

Paclitaxel and Carboplatin in Treating Women Who Are Undergoing Surgery for Newly Diagnosed, Locally Advanced Breast Cancer

NCT00096343

Conditions: Adenocarcinoma, Breast Cancer, Breast Diseases, +13 more
Locations: University of Alabama at Birmingham Comprehensive Cancer Center Birmingham, Alabama, United States

View Trial Details

Completed

MUC1 Vaccine for Triple-negative Breast Cancer

NCT00986609

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +13 more
Locations: Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details